How soon does Wegovy take effect — and what should you feel first?

What do most people notice in the first one or two weeks?

The earliest signal is usually a shift in hunger rather than a number on the scales. People describe feeling full sooner at meals, less preoccupied with food between them, or simply less likely to reach for a snack in the afternoon. This is semaglutide beginning to act on GLP-1 receptors in the brain and gut, slowing gastric emptying and dialling down appetite signalling. It can feel subtle (not a dramatic switch) but it is real.

Weight change at this stage is modest. A pound or two in the first fortnight is typical; some people see nothing yet on the scales. That is not a sign of failure. The 0.25mg starting dose exists specifically to ease your system into treatment and reduce the chance of nausea, not to produce maximum weight loss. Think of it as the medicine finding its footing. Side effects, if they appear at all, tend to be at their most noticeable here: mild nausea, loose stools, or a slightly unsettled stomach are common and usually settle within a few days to two weeks, as the NHS's patient information on semaglutide explains.

One practical thing worth noting: if you want a clearer sense of the timeline before your first pen even arrives, our guide covering when Wegovy takes effect explains what to realistically expect in those opening days and beyond. Building your injection day into a regular weekly routine early on makes this easier to track.

When do the effects of Wegovy really start building?

The dose-increase schedule is where most of the story lives. Each step up (roughly every four weeks, guided by your prescriber) adds both appetite suppression and the potential for stronger side effects. Many people report that the jump to 1mg or 1.7mg is where weight loss starts feeling more consistent. Portions shrink without much effort. Food preoccupation fades. Energy can shift too, partly because carrying less weight demands less of your body, partly because the hormonal effects of semaglutide extend beyond appetite alone.

By months two to four, with the dose climbing steadily, the cumulative effect becomes clearer on the scales. This is also the window where the broader effects of Wegovy (on blood pressure, blood sugar, and general metabolic markers) can begin to show in blood results, which is worth discussing with your prescriber at review. The process is gradual by design. Rapid weight loss carries its own risks, and the titration schedule reflects years of trial design rather than pharmaceutical caution for its own sake.

If you are curious about what to expect at specific stages, our guide on how soon Wegovy works goes into the week-by-week picture in more detail.

What does the clinical evidence say about longer-term results?

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults with obesity or overweight plus a weight-related condition over 68 weeks. At the 2.4mg maintenance dose, participants lost an average of around 15% of body weight, compared with around 2.4% in the placebo group. These are group averages; individual results varied, and loss continued accumulating throughout the trial rather than plateauing early.

The newer 7.2mg dose, approved by the MHRA in early 2026, showed around 20.7% average weight loss over 72 weeks in trials, narrowing the gap with tirzepatide results. If you want to understand where Wegovy sits relative to other licensed options, our overview of semaglutide for weight management covers the comparison evidence.

Results are not guaranteed and depend on sustained treatment, lifestyle changes alongside it, and individual biology. What the trial data does confirm is that meaningful effect takes time, months, not days. Anyone expecting dramatic results in week one will be disappointed, and that expectation is worth resetting early.

What if Wegovy seems to have stopped working or never started?

This is one of the most common questions our prescribers hear. There are a few distinct situations it covers. First, the starting dose genuinely producing minimal weight loss is expected and is not a problem. Second, a plateau at higher doses after several months is different and worth a clinical conversation, dose, diet, medication interactions, and underlying factors all play a part. Third, some people find a specific dose increase produces less effect than the previous one, which can reflect how the body adapts.

Our page on Wegovy having no effect sets out the practical questions to ask and when to flag something with your prescriber. The short version: if you are not seeing any change after six months on the highest tolerated dose, the NICE guidance on semaglutide recommends reviewing whether continuing is the right call. That decision sits with your prescriber, not with a fixed rule.

Cost is sometimes part of the picture too, people reduce doses themselves to stretch a pen further, which changes efficacy unpredictably. If cost context is useful, our Wegovy pricing page explains what legitimate private treatment includes and why headline prices can be misleading.